These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 2144361
1. [Prolactin receptors and breast cancer]. Basilio E, Prats M, Rivera F. Rev Esp Fisiol; 1990 Mar; 46(1):57-8. PubMed ID: 2144361 [Abstract] [Full Text] [Related]
2. Characterization of prolactin receptors and their distribution among American and Israeli women with breast cancer: implications for prediction of hormonal dependency and treatment. Ben-David M, Kadar T, Wittliff J, Biran S, Schally A. Biomed Pharmacother; 1988 Mar; 42(2):101-9. PubMed ID: 3167163 [Abstract] [Full Text] [Related]
8. Prolactin and prolactin binding sites in human breast cancer cells. Marchetti E, Rimondi AP, Querzoli P, Fabris G, Nenci I. Prog Clin Biol Res; 1984 Sep 01; 142():109-17. PubMed ID: 6324233 [No Abstract] [Full Text] [Related]
9. [In vitro hormone tests in human breast cancers and their relevance for therapy of metastasizing breast cancer]. Schönfelder M. Zentralbl Chir; 1987 Sep 01; 112(18):1150-4. PubMed ID: 3687263 [Abstract] [Full Text] [Related]
12. [Hormone receptors in breast cancer]. Navarra S, Melita P, Di Mauro S, Calbo L, Belnome N. Minerva Med; 1981 May 19; 72(20):1277-82. PubMed ID: 6264354 [Abstract] [Full Text] [Related]
13. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D). Leroy-Martin B, Peyrat JP. Anticancer Res; 1989 May 19; 9(3):631-6. PubMed ID: 2764510 [Abstract] [Full Text] [Related]
14. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease. England PC, Sellwood RA, Knyba RE, Irvine JD. Clin Oncol; 1981 Sep 19; 7(3):213-9. PubMed ID: 6211319 [No Abstract] [Full Text] [Related]
15. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma. Bhatavdekar JM, Shah NG, Trivedi SN, Karelia NH. Neoplasma; 1987 Sep 19; 34(1):95-9. PubMed ID: 3104809 [Abstract] [Full Text] [Related]
16. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors. Kiss R, de Launoit Y, Danguy A, Paridaens R, Pasteels JL. Cancer Res; 1989 Jun 01; 49(11):2945-51. PubMed ID: 2720654 [Abstract] [Full Text] [Related]
17. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Murphy LC, Lee-Wing M, Goldenberg GJ, Shiu RP. Cancer Res; 1987 Aug 01; 47(15):4160-4. PubMed ID: 3607757 [Abstract] [Full Text] [Related]
18. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer. Calandra RS, Charreau EH, Royer de Giaroli M, Baldi A. Prog Clin Biol Res; 1984 Aug 01; 142():97-108. PubMed ID: 6709661 [Abstract] [Full Text] [Related]
19. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Cancer Res; 2004 Sep 15; 64(18):6814-9. PubMed ID: 15375001 [Abstract] [Full Text] [Related]